Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02879643
Title	Vincristine Sulfate Liposome Injection (Marqibo) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL
Recruitment	Unknown status
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Therapeutic Advances in Childhood Leukemia Consortium
Indications	childhood acute lymphocytic leukemia acute leukemia lymphoblastic lymphoma
Therapies	Dexamethasone + Methotrexate + Pegaspargase + Vincristine sulfate liposome Dexamethasone + Mercaptopurine + Methotrexate + Vincristine sulfate liposome Dexamethasone + Methotrexate + Mitoxantrone + Pegaspargase + Vincristine sulfate liposome
Age Groups:	adult \| child
Covered Countries	USA \| CAN \| AUS